🚀 VC round data is live in beta, check it out!
RTW Biotech Opportunities Valuation Multiples
Discover revenue and EBITDA valuation multiples for RTW Biotech Opportunities and similar public comparables like Carlton Investments, Care Property Invest, Investment AB Oresund, Qualitas and more.
RTW Biotech Opportunities Overview
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon. Geographically, it operates in U.S. &Canada, UK & EU, and Rest of the world.
Founded
2017
HQ
Employees
0
Website
Sectors
Financials (FY)
EV
$672M
RTW Biotech Opportunities Financials
RTW Biotech Opportunities reported last fiscal year revenue of $39M.
In the same fiscal year, RTW Biotech Opportunities generated $34M in net income.
RTW Biotech Opportunities P&L
In the most recent fiscal year, RTW Biotech Opportunities reported revenue of $39M and net income of $34M.
RTW Biotech Opportunities expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $39M | XXX | XXX | XXX |
| Net Profit | — | XXX | $34M | XXX | XXX | XXX |
| Net Margin | — | XXX | 88% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
RTW Biotech Opportunities Stock Performance
RTW Biotech Opportunities has current market cap of $672M, and enterprise value of $672M.
Market Cap Evolution
RTW Biotech Opportunities' stock price is $2.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $672M | $672M | 0.0% | XXX | XXX | XXX | $0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRTW Biotech Opportunities Valuation Multiples
RTW Biotech Opportunities trades at 17.4x EV/Revenue multiple.
RTW Biotech Opportunities Financial Valuation Multiples
As of March 23, 2026, RTW Biotech Opportunities has market cap of $672M and EV of $672M.
Equity research analysts estimate RTW Biotech Opportunities' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
RTW Biotech Opportunities has a P/E ratio of 19.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $672M | XXX | $672M | XXX | XXX | XXX |
| EV (current) | $672M | XXX | $672M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 17.4x | XXX | XXX | XXX |
| P/E | — | XXX | 19.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (5.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified RTW Biotech Opportunities Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
RTW Biotech Opportunities Margins & Growth Rates
RTW Biotech Opportunities' revenue in the last fiscal year declined by (55%).
RTW Biotech Opportunities Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (55%) | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
RTW Biotech Opportunities Public Comps
See public comps and valuation multiples for other Asset Management and PE & VC comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Carlton Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Care Property Invest | XXX | XXX | XXX | XXX | XXX | XXX |
| Investment AB Oresund | XXX | XXX | XXX | XXX | XXX | XXX |
| Qualitas | XXX | XXX | XXX | XXX | XXX | XXX |
| Kuyaş Yatırım | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
RTW Biotech Opportunities M&A Activity
RTW Biotech Opportunities acquired XXX companies to date.
Last acquisition by RTW Biotech Opportunities was on XXXXXXXX, XXXXX. RTW Biotech Opportunities acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by RTW Biotech Opportunities
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRTW Biotech Opportunities Investment Activity
RTW Biotech Opportunities invested in XXX companies to date.
RTW Biotech Opportunities made its latest investment on XXXXXXXX, XXXXX. RTW Biotech Opportunities invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by RTW Biotech Opportunities
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout RTW Biotech Opportunities
| When was RTW Biotech Opportunities founded? | RTW Biotech Opportunities was founded in 2017. |
| Where is RTW Biotech Opportunities headquartered? | RTW Biotech Opportunities is headquartered in United Kingdom. |
| How many employees does RTW Biotech Opportunities have? | As of today, RTW Biotech Opportunities has over 0 employees. |
| Is RTW Biotech Opportunities publicly listed? | Yes, RTW Biotech Opportunities is a public company listed on London Stock Exchange. |
| What is the stock symbol of RTW Biotech Opportunities? | RTW Biotech Opportunities trades under RTW ticker. |
| Who are competitors of RTW Biotech Opportunities? | RTW Biotech Opportunities main competitors are Carlton Investments, Care Property Invest, Investment AB Oresund, Qualitas. |
| What is the current market cap of RTW Biotech Opportunities? | RTW Biotech Opportunities' current market cap is $672M. |
| What is the current revenue of RTW Biotech Opportunities? | RTW Biotech Opportunities' last fiscal year revenue is $39M. |
| What is the current EV/Revenue multiple of RTW Biotech Opportunities? | Current revenue multiple of RTW Biotech Opportunities is 17.4x. |
| Is RTW Biotech Opportunities profitable? | No, RTW Biotech Opportunities is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.